MQR — Multiqure SA Share News
0.000.00%
- PLN342.69m
- PLN292.64m
Brief: Pure Biologics Gets 4.5 Mln Zloty Advance From Poland's NCBR
Brief: Pure Biologics Gets Second 2.0 Mln Zloty Advance From National Centre For Research And Development
Brief: Pure Biologics Files To Polish Financial Regulator KNF For Approval Of Prospectus Regarding Co's Shares
Brief: Pure Biologics Gets 3.0 Mln Zloty Subsidy For PB004 Drug Development Project
Brief: Pure Biologics Intends To Move Trading Of Its Shares To WSE Main Market
Brief: Pure Biologics Q1 Net Loss Widens To 1.6 Mln Zlotys
Brief: Pure Biologics FY Net Loss Widens To 4.5 Mln Zlotys
Brief: Pure Biologics Q4 Net Loss Widens To 2.0 Mln Zlotys
Brief: Pure Biologics Announces Stake Changes
Brief: Pure Biologics Q3 Net Loss Widens To 0.9 Mln Zlotys
Brief: Pure Biologics Gets 1.1 Mln Zloty Subsidy For AptaMLN Project
Brief: Pure Biologics Receives Patent For Its Invention From United States Patent And Trademark Office
Brief: Pure Biologics Signs 29.9 Mln Zloty Subsidy Agreement With Poland's NCBR
Brief: Pure Biologics Gets Positive Decision From PARP Regarding Financing Of Co's Product Brands On Foreign Markets
Brief: Pure Biologics Q2 Net Loss Widens To 1.2 Mln Zlotys
Brief: Pure Biologics Gets 10.8 Mln Zloty Subsidy From NCBR
Brief: Pure Biologics Announces Its Shareholder Stake Changes
Brief: Pure Biologics Q1 Net Loss Widens To 0.4 Mln Zlotys
Brief: Pure Biologics Updates On Share Capital Increase